Agios Pharmaceuticals, Inc. announced its anticipated milestones for 2026 in a press release dated January 12, 2026, to be discussed at the J.P. Morgan Healthcare Conference on January 14, 2026. The filing includes detailed presentations and is not considered 'filed' under SEC regulations.